We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Blood Culture Media Evaluated For Detection of Pathogenic Fungi

By LabMedica International staff writers
Posted on 20 Jan 2015
Print article
Becton, Dickinson and Company\'s BACTEC 9240 Blood Culture System
The BACTEC 9240 Blood Culture System (Photo courtesy of BD DIAGNOSTIC SOLUTIONS)
A growing number of fungemia cases have been observed in recent decades and Candida species have been placed as the fourth most common microorganism isolated from blood samples.

Many cases of invasive mycoses, including invasive candidiasis, remain undiagnosed, mostly because of the insufficient sensitivity of blood cultures, which has been estimated as low as 50%. In order to improve the early diagnosis of invasive fungal diseases, several serological tests detecting fungal biomarkers, such as antigens, DNA, or specific antibodies, have been developed, of which only a few have gained acceptance for routine diagnostics.

Microbiologists at the Medical University of Wroclaw (Poland) compare the utility of different media in the detection of fungi from simulated tests obtained by the inoculation of tested media first with sterile sheep’s blood and subsequently with one of 60 clinical yeast isolates and clinical blood samples, taken during routine diagnostic examination in two hospitals.

The blood culture bottles BACTEC Mycosis-IC/F (Mycosis), BACTEC Plus Aerobic/F (Aerobic), and BACTEC Plus Anaerobic/F (Anaerobic) (BACTEC; Dartford, UK) were inoculated aseptically with sterile sheep’s blood and subsequently with of fungal suspension containing 10 to 20 fungal cells. The samples were immediately placed in the compartment of the BACTEC 9240 Blood Culture System (Becton, Dickinson and Company; Franklin Lakes, NJ, USA) and incubated until positivity, 5 days for Aerobic and Anaerobic, and 14 days for Mycosis.

All tested strains grew on Mycosis as well as Aerobic bottles, and the time to detection obtained for Mycosis was significantly shorter. The largest differences in the time to positivity were found for Candida glabrata and Cryptococcus neoformans, when Mycosis preceded Aerobic in 20 to 48 hours and 0.7 to 64 hours, respectively. The media complement each other and, in 45% of clinical examination sets, a single positive medium was noted with 25% in Mycosis and 19% in Aerobic.

The authors concluded that that both Aerobic and Mycosis media serve as the correct condition for the culture of fungi and that they varied significantly in the detection time of clinically important species. This result could suggest that the simultaneous use of Aerobic as well as Mycosis media may improve the time of diagnosis in many patients, especially those infected with C. glabrata or C. neoformans. The study was published in the January 2015 issue of the European Journal of Clinical Microbiology and Infectious Diseases.

Related Links:

Medical University of Wroclaw 
BACTEC
Becton, Dickinson and Company 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.